Inoue M, Hirabayashi M, Abe SK, Katanoda K, Sawada N, Lin Y, et al. Burden of cancer attributable to modifiable factors in Japan in 2015. Glob Health Med. 2022;4:26–36.
Article PubMed PubMed Central Google Scholar
Mesri EA, Feitelson MA, Munger K. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe. 2014;15(3):266–82. https://doi.org/10.1016/j.chom.2014.02.011.
Article PubMed PubMed Central CAS Google Scholar
Krump NA, You J. Molecular mechanisms of viral oncogenesis in humans. Nat Rev Microbiol. 2018;16(11):684–98. https://doi.org/10.1038/s41579-018-0064-6.
Article PubMed PubMed Central CAS Google Scholar
Xiao Q, Liu Y, Li T, Wang C, He S, Zhai L, et al. Viral oncogenesis in cancer: from mechanisms to therapeutics. Signal Transduct Target Ther. 2025;10(1):151.
Article PubMed PubMed Central Google Scholar
Matsuoka M, Jeang K. T: Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270–80.
Article PubMed CAS Google Scholar
Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4(10):757–68.
Article PubMed CAS Google Scholar
Cesarman E. Gammaherpesviruses and lymphoproliferative disorders. Annu Rev Pathol. 2014;9:349–72.
Article PubMed CAS Google Scholar
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980;77:7415–9.
Article PubMed PubMed Central CAS Google Scholar
Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA. 1982;79:2031–5.
Article PubMed PubMed Central CAS Google Scholar
Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476–80.
Article PubMed PubMed Central CAS Google Scholar
Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.
Article PubMed PubMed Central Google Scholar
Uchiyama T, Yodoi H, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.
Article PubMed CAS Google Scholar
Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15:e517–26.
Article PubMed CAS Google Scholar
Watanabe T. Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1–infected T cells. Blood. 2017;129:1071–81.
Article PubMed PubMed Central CAS Google Scholar
Bangham CRM. HTLV-1 persistence and the oncogenesis of adult T cell leukemia/lymphoma. Blood. 2023;141:2299–306.
PubMed PubMed Central CAS Google Scholar
Shichijo T, Yasunaga JI. Human T-cell leukemia virus type I: modulation of viral gene expression and perturbation of host signaling pathways lead to persistent infection. Curr Opin Virol. 2025;73:101480. https://doi.org/10.1016/j.coviro.2025.101480.
Article PubMed CAS Google Scholar
Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y, et al. Treatment and survival among 1594 patients with ATL. Blood. 2015;126:2570–7.
Article PubMed CAS Google Scholar
Imaizumi Y, Iwanaga M, Nosaka K, Ishitsuka K, Ishizawa K, Ito S, et al. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: a nationwide hospital-based study. Cancer Sci. 2020;111:4567–80.
Article PubMed PubMed Central CAS Google Scholar
Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L, et al. Revised adult T-cell leukemia-lymphoma international consensus meeting report. J Clin Oncol. 2019;37:677–87. https://doi.org/10.1200/JCO.18.00501.
Article PubMed PubMed Central CAS Google Scholar
Cook LB, Phillips A. A: How I treat adult T-cell leukemia/lymphoma. Blood. 2021;137:459–70.
Article PubMed CAS Google Scholar
Yoshimitsu M, Choi I, Kusumoto S, Shimokawa M, Utsunomiya A, Suehiro Y, et al. A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma. Blood. 2025;146(12):1440–9. https://doi.org/10.1182/blood.2024027902.
Article PubMed CAS Google Scholar
Shichijo T, Nosaka K, Tatetsu H, Higuchi Y, Endo S, Inoue Y, et al. Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma. Br J Haematol. 2022;198:983–7. https://doi.org/10.1111/bjh.18281.
Article PubMed CAS Google Scholar
Izutsu K, Makita S, Nosaka K, Yoshimitsu M, Utsunomiya A, Kusumoto S, et al. An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma. Blood. 2023;141(10):1159–68.
Article PubMed CAS Google Scholar
Shichijo T, Tatetsu H, Higuchi Y, Miyakawa T, Nosaka K, Nakamura T, et al. Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma. Br J Haematol. 2025. https://doi.org/10.1111/bjh.70219.
Shichijo T, Yasunaga JI. Stratagems of HTLV-1 for persistent infection and the resultant oncogenesis: immune evasion and clonal expansion. Leuk Res. 2025;152:107680. https://doi.org/10.1016/j.leukres.2025.107680.
Article PubMed CAS Google Scholar
Sun SC, Yamaoka S. Activation of NF-κB by HTLV-I and implications for cell transformation. Oncogene. 2005;24:5952–64.
Article PubMed CAS Google Scholar
Zhao T, Wang Z, Fang J, Cheng W, Zhang Y, Huang J, et al. HTLV-1 activates YAP via NF-kappaB/p65 to promote oncogenesis. Proc Natl Acad Sci USA. 2022;119:e2115316119. https://doi.org/10.1073/pnas.2115316119.
Article PubMed PubMed Central CAS Google Scholar
Robek MD, Ratner L. Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 tax mutants expressed in a functional molecular clone. J Virol. 1999;73:4856–65.
Article PubMed PubMed Central CAS Google Scholar
Okamoto K, Fujisawa J, Reth M, Yonehara S. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB. Genes Cells. 2006;11:177–91.
Comments (0)